Oncolytics Biotech/ CA6823101077 /
| 10/11/2024 9:56:03 PM | Chg. +0.02 | Volume | Bid10:25:00 PM | Ask10:25:00 PM | High | Low |
|---|---|---|---|---|---|---|
| 1.25USD | +1.22% | 13,492 Turnover: 15,678.70 |
0.96Bid Size: 2 | 1.45Ask Size: 85 | 1.26 | 1.22 |
GlobeNewswire
6/20
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Gr...
GlobeNewswire
6/20
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7...
GlobeNewswire
5/24
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7...
Newsfile Corp
3/6
Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning
GlobeNewswire
3/5
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Trea...
Newsfile Corp
2/15
Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments
GlobeNewswire
2/14
Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focu...
GlobeNewswire
1/9
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
GlobeNewswire
12/12/2018
Oncolytics Biotech® Announces First Patient Treated in Study Combining Pelareorep, Carfilzomib and t...
GlobeNewswire
12/3/2018
Oncolytics Biotech® Announces Increased PD-L1 Expression When Combining Pelareorep with a Proteasom...
GlobeNewswire
11/29/2018
Oncolytics Biotech® Announces Appointment of Rita Laeufle, M.D., as Chief Medical Officer
GlobeNewswire
11/26/2018
Oncolytics Biotech® Announces First Patient Treated in Phase 2 Study Combining Pelareorep and Keytru...
GlobeNewswire
11/12/2018
Oncolytics Biotech® Reports 2018 Third Quarter Financial Results and Provides Corporate Update
GlobeNewswire
11/9/2018
Oncolytics Biotech® Announces Presentation at the Society for Immunotherapy of Cancer 2018 Annual Me...
GlobeNewswire
11/5/2018
Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Corporat...
GlobeNewswire
11/1/2018
Oncolytics Biotech® Announces Abstract for ASH Annual Meeting & Exposition Demonstrating Pelareorep ...
GlobeNewswire
10/22/2018
Oncolytics Biotech® Announces Positive Clinical Trial Results for Pelareorep in Patients with KRAS M...
GlobeNewswire
10/11/2018
Oncolytics Biotech® Announces Publication of Positive Clinical Results for Pelareorep in Abstract f...
GlobeNewswire
10/2/2018
Oncolytics Biotech® Announces a Publication Demonstrating That Intravenously Delivered Oncolytic Vir...
GlobeNewswire
9/28/2018
Oncolytics Biotech® Enters into Common Stock Purchase Agreement for up to US$26 Million with Lincoln...
GlobeNewswire
9/26/2018
Oncolytics Biotech® to Present at the Ladenburg Thalmann 2018 Healthcare Conference
